We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Arrow International for Numerous Quality Violations
FDA Warns Arrow International for Numerous Quality Violations
August 12, 2005
The FDA has issued Arrow International a warning letter charging the medical device manufacturer with violating both cGMP and quality system (QS) regulations.